EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiovascular risk reduction: Past, present and future in Mexico

Martin Rosas-Peralta, Gabriela Borrayo-Sánchez, Erick Ramírez-Arias, Gladys M Jiménez-Genchi, Martha Alicia Hernández-González, Rafael Barraza-Félix, Lidia Evangelina Betacourt-Hernández, Rocio Camacho-Casillas, Rodolfo Parra-Michel, Héctor David Martínez Chapa, José de Jesús Arriaga-Dávila

Annals of Clinical Hypertension · 2018

DOI: 10.29328/journal.ach.1001010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical Hypertension, 2018. Verfasst von Martin Rosas-Peralta und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerotic cardiovascular disease (ASCVD) is globally defined as coronary heart disease, cerebrovascular disease, or peripheral arterial disease presumed to be of atherosclerotic origin and it is the leading cause of morbidity and mortality for individuals with or without diabetes and is the largest contributor to the direct and indirect catastrophic costs of cardiovascular disorder. Very common conditions coexisting into the cardiovascular risk (e.g., obesity, hypertension, diabetes and dyslipidemia) are clear risk factors for ASCVD, and diabetes itself confers independent risk. Numerous studies have shown the efficacy of controlling individual cardiovascular risk factors in preventing or slowing ASCVD in people with these disorders. In other words it is not enough control one risk factor. We need to develop novel strategies to detect and control all of them at the same time. Thus, large benefits are seen when multiple cardiovascular risk factors are addressed simultaneously. Under the current paradigm of aggressive risk factor modification in patients with cardiovascular risk, there is evidence that measures of 10-year coronary heart disease (CHD) risk among U.S. adults with cardiovascular risk have improved significantly over the past decade and that ASCVD morbidity and mortality have decreased. In Mexico the Mexican Institute of Social Security is implementing new strategies of primary and secondary prevention in order to confront this pandemic. In this review, we analyze the state of the art to approach at the same time the different cardiovascular risk factors, in an integral form because of this is the real worldwide challenge of health.

Zitieren

APA

Rosas-Peralta, M., Borrayo-Sánchez, G., Ramírez-Arias, E., Jiménez-Genchi, G. M., Hernández-González, M. A., Barraza-Félix, R., Betacourt-Hernández, L. E., Camacho-Casillas, R., Parra-Michel, R., Chapa, H. D. M., & Arriaga-Dávila, J. D. J. (2018). Cardiovascular risk reduction: Past, present and future in Mexico. Annals of Clinical Hypertension. https://doi.org/10.29328/journal.ach.1001010

Vancouver

Rosas-Peralta M, Borrayo-Sánchez G, Ramírez-Arias E, Jiménez-Genchi GM, Hernández-González MA, Barraza-Félix R, et al. Cardiovascular risk reduction: Past, present and future in Mexico. Annals of Clinical Hypertension. 2018. doi:10.29328/journal.ach.1001010

BibTeX
@article{RosasPeralta2018,
  author = {Rosas-Peralta, Martin and Borrayo-Sánchez, Gabriela and Ramírez-Arias, Erick and Jiménez-Genchi, Gladys M and Hernández-González, Martha Alicia and Barraza-Félix, Rafael and Betacourt-Hernández, Lidia Evangelina and Camacho-Casillas, Rocio and Parra-Michel, Rodolfo and Chapa, Héctor David Martínez and Arriaga-Dávila, José de Jesús},
  title = {Cardiovascular risk reduction: Past, present and future in Mexico},
  journal = {Annals of Clinical Hypertension},
  year = {2018},
  doi = {10.29328/journal.ach.1001010}
}
Kostenlos starten →